Digena

BiotechnologySeries BHangzhou, Chinadigena.com.cn

Latest round

Series B

Last raised

Mar 2022

Total raised

$16M

Investors

5

About Digena

Based in Hangzhou, China and established in 2018, Digena operates as a biotechnology company that provides diagnostic equipment and diagnostic kit. The company has partnerships with Dian Diagnostics, Agena Bioscience, CITIC Securities, and other companies. The company's products can be categorized into technology platforms, reagent products, and software products. Some of the main products within the technology platform category include nucleic acid mass spectrometer, and nanopore single molecule sequencer. Its nanopore single molecule sequencer can analyze DNA or RNA fragments in real time. It works by monitoring the current change when nucleic acid passes through nanopores, and decoding the current signal to determine the base sequence. Its reagent products can be applied in genetic diseases, pharmacogenomics, oncology, infectious diseases and health management.

Who invested in Digena

5 investors across 2 rounds

See all investors in Digena

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 14, 2022

    Amount

    $16M

    Investors

    Locked

  2. Series A

    Oct 28, 2020

    Amount

    Undisclosed

    Investors

    Locked

Questions about Digena

Who invested in Digena?

Digena has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Digena raised?

Digena has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Digena last raise money?

Digena's most recent round on record is a Series B, in Mar 2022.

What does Digena do?

Based in Hangzhou, China and established in 2018, Digena operates as a biotechnology company that provides diagnostic equipment and diagnostic kit.

Where is Digena headquartered?

Digena is headquartered in Hangzhou, China.

Which VCs invest in companies like Digena?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Digena's stage. Their profiles are linked below.

Raising like Digena? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.